The growing burden of many neurological conditions such as Alzheimer’s or Parkinson’s disease, multiple sclerosis and chronic pain threatens to overwhelm healthcare resources. While there are many opportunities for new neurological therapeutics, the connections between target and neurological diseases are only slowly being elucidated.
tranScrip’s expertise and capabilities in neurology extend across a wide range of indications such as epilepsy, neurodegenerative diseases, stroke, sleep disorders, depression, schizophrenia, ADHD and pain.
We cover all phases of the product lifecycle and support and guide our clients to meet their targets even if this means challenging the current clinical and regulatory paradigms.
We provide strategic expertise, therapeutic experience and operational excellence across the entire product lifecycle.
Senior Vice President, Clinical Development and External Innovation
Biosplice Therapeutics, Inc.
Our experienced physicians and scientists, together with our regulatory, clinical and commercial experts can support you to maximise the value of your products. Whatever your project requires, we have the expertise to meet your needs.